Regenxbio (RGNX) Net Margin Growth (1y) (2015 - 2025)
Regenxbio (RGNX) Net Margin Growth (1y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Regenxbio |
325.94 Mn |
95.87 Mn |
- |
2,027.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
2,027.00 |
| Sep 30, 2025 |
3,801.00 |
| Jun 30, 2025 |
-9,410.00 |
| Mar 31, 2025 |
41,243.00 |
| Dec 31, 2024 |
4,180.00 |
| Sep 30, 2024 |
-3,243.00 |
| Jun 30, 2024 |
12,292.00 |
| Mar 31, 2024 |
-5,723.00 |
| Dec 31, 2023 |
-98,664.00 |
| Sep 30, 2023 |
7,074.00 |
| Jun 30, 2023 |
-15,190.00 |
| Mar 31, 2023 |
-308.00 |
| Dec 31, 2022 |
62,941.00 |
| Sep 30, 2022 |
-9,492.00 |
| Jun 30, 2022 |
5,276.00 |
| Mar 31, 2022 |
-7,981.00 |
| Dec 31, 2021 |
28,938.00 |
| Sep 30, 2021 |
-19,868.00 |
| Jun 30, 2021 |
-5,778.00 |
| Mar 31, 2021 |
-3,859.00 |
